Syngene International Limited (SYNGENE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

Based on the latest financial reports, Syngene International Limited (SYNGENE) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-451.00 Million ≈ $-4.88 Million USD) by net assets (Rs47.35 Billion ≈ $512.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SYNGENE market cap for the company's overall valuation and market capitalisation.

Syngene International Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Syngene International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Syngene International Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syngene International Limited ranked by their cash flow conversion efficiency. Explore Syngene International Limited (SYNGENE) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
NP3 Fastigheter AB ST:NP3	0.016x
Sihui Fuji Electronics Technology Co Ltd SHE:300852	0.026x
Guangdong Guangzhou Daily Media Co Ltd SHE:002181	0.028x
Perpetual Ltd AU:PPT	0.035x
Opera Ltd NASDAQ:OPRA	0.022x
Jiangsu Eazytec Co Ltd SHG:688258	0.025x
Grg Metrology SHE:002967	0.036x
Gas Malaysia Bhd KLSE:5209	0.049x

Annual Cash Flow Conversion Efficiency for Syngene International Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Syngene International Limited from 2010 to 2025. View Syngene International Limited (SYNGENE) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs47.27 Billion ≈ $511.19 Million	Rs11.68 Billion ≈ $126.27 Million	0.247x	+0.93%
2024-03-31	Rs42.58 Billion ≈ $460.46 Million	Rs10.42 Billion ≈ $112.70 Million	0.245x	+5.62%
2023-03-31	Rs36.18 Billion ≈ $391.27 Million	Rs8.38 Billion ≈ $90.67 Million	0.232x	+31.61%
2022-03-31	Rs32.98 Billion ≈ $356.62 Million	Rs5.81 Billion ≈ $62.79 Million	0.176x	-29.16%
2021-03-31	Rs28.21 Billion ≈ $305.12 Million	Rs7.01 Billion ≈ $75.83 Million	0.249x	-20.14%
2020-03-31	Rs21.76 Billion ≈ $235.30 Million	Rs6.77 Billion ≈ $73.23 Million	0.311x	-2.83%
2019-03-31	Rs19.68 Billion ≈ $212.87 Million	Rs6.30 Billion ≈ $68.18 Million	0.320x	+23.48%
2018-03-31	Rs17.20 Billion ≈ $186.05 Million	Rs4.46 Billion ≈ $48.25 Million	0.259x	-7.85%
2017-03-31	Rs14.13 Billion ≈ $152.82 Million	Rs3.98 Billion ≈ $43.01 Million	0.281x	-5.15%
2016-03-31	Rs10.53 Billion ≈ $113.86 Million	Rs3.12 Billion ≈ $33.78 Million	0.297x	+1255.19%
2015-03-31	Rs8.45 Billion ≈ $91.37 Million	Rs185.00 Million ≈ $2.00 Million	0.022x	-95.18%
2014-03-31	Rs6.59 Billion ≈ $71.30 Million	Rs3.00 Billion ≈ $32.39 Million	0.454x	+127.62%
2013-03-31	Rs5.19 Billion ≈ $56.08 Million	Rs1.03 Billion ≈ $11.19 Million	0.200x	-51.53%
2012-03-31	Rs2.97 Billion ≈ $32.10 Million	Rs1.22 Billion ≈ $13.22 Million	0.412x	+13.87%
2011-03-31	Rs2.21 Billion ≈ $23.87 Million	Rs798.00 Million ≈ $8.63 Million	0.362x	-14.05%
2010-03-31	Rs1.94 Billion ≈ $20.93 Million	Rs814.00 Million ≈ $8.80 Million	0.421x	--

About Syngene International Limited

NSE:SYNGENE India Diagnostics & Research

Market Cap

$1.60 Billion

Rs148.25 Billion INR

Market Cap Rank

#7014 Global

#335 in India

Share Price

Rs369.05

Change (1 day)

-2.93%

52-Week Range

Rs369.05 - Rs663.85

All Time High

Rs947.80